ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Massachusetts General Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Massachusetts General Hospital takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans treatment and tumor biology in lung, breast, head and neck, and gastrointestinal cancers. It examines ordastobart with pembrolizumab as initial treatment for recurrent or metastatic head and neck cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Teaching hospital of Harvard Medical School in Boston, Massachusetts, with a cancer centre.
Poster
Fri Oct 23
13:00–15:00
Immune-molecular phenotypes and therapeutic surface antigen expression in nasopharyngeal carcinoma
ePoster session 22
Sarcoma, CNS, head & neck and rare cancers
Satellite
Fri Oct 23
18:20–18:40
The biological landscape: Drivers of HR+ HER2- mBC treatment decisions
F. Hoffmann - La Roche LTD - From evidence to action in HR+ HER2- mBC
Breast cancer
Satellite
Fri Oct 23
18:40–19:00
Advances in 1L therapy for metastatic NSCLC: Current and emerging biomarkers and treatment strategies
AstraZeneca - Advancing excellence in lung cancer: New biomarkers, novel combinations, and changing standards of care
Lung & thoracic cancersBiomarkers & precision oncology
Satellite
Fri Oct 23
19:40–19:45
Close
F. Hoffmann - La Roche LTD - From evidence to action in HR+ HER2- mBC
Breast cancer
Talk
Sun Oct 25
09:00
Complex IO toxicities management
YO Clinical case discussions · with Fudan University Shanghai Cancer Center
Abstract
Mon Oct 26
08:50–09:02
Invited Discussant LBA69, 2615O
Proffered paper 2: NSCLC, metastatic
Lung & thoracic cancers
Satellite
Mon Oct 26
13:10–13:30
Clinical decision point 1: Should CDK4/6 inhibitors be considered for patients with nodal involvement?
Novartis - From Risk to Recurrence: Personalizing CDK4/6 Inhibitor Strategies in HR+/HER2− Breast Cancer
Breast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Massachusetts General Hospital

Tell us what you sell and we’ll find the people at Massachusetts General Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction